NeoRx: NeuroVir's replicating vectors

With the acquisition of NeuroVir Therapeutics Inc. last week, MediGene AG has picked up a technology platform for production of herpes simplex virus (HSV) vectors and two products in the clinic. The HSV technology complements MediGene's existing vector

Read the full 381 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE